An Ozempic-like drug prescribed for diabetes has been found to reduce the frequency of debilitating migraine. Researchers say ...

Researchers found that tirzepatide, a medication primarily used for treating type 2 diabetes and weight loss, reduced body ...

Study finds the GLP-1 drug liraglutide reduced migraine days by almost 50% in patients with obesity, with quality of life ...

A current weight-loss and diabetes drug has become a surprise candidate for migraine treatment, with a new pilot study ...

A new study finds four factors that may make it more likely for some people to experience successful weight loss from using ...

Researchers found that tirzepatide, a medication primarily used for treating type 2 diabetes and weight loss, reduced body weight ...

An Ozempic-like drug prescribed for diabetes has been found to reduce the frequency of debilitating migraine. Researchers say liraglutide, a GLP-1RA, might help migraine by reducing intracranial ...

A recent study suggests that liraglutide, a drug similar to Ozempic, may reduce migraine frequency in obese individuals with ...

Subsequent hospitalization rates were lower among patients with type 2 diabetes who received liraglutide compared with glimepiride.

For adults with obesity and migraine, liraglutide reduces migraine burden, with reductions in mean monthly headache days.

Researchers found that tirzepatide, a medication primarily used for treating type 2 diabetes and weight loss, reduced body weight, food intake and many measures of appetite more than placebo and ...